News
Formula for success: Dal chemistry postdoc named to two prestigious programs for emerging science leaders
Known for rethinking materials production and championing inclusive science, Dr. Blaine Fiss is gaining global recognition and momentum as he moves toward the next stage of his academic career. Read more.
Featured News
Friday, April 17, 2026
Unique in Canada, the four‑year joint JD/MJ program links legal training with journalism practice to prepare graduates for work at the intersection of media, law and public policy.
Thursday, April 2, 2026
Dalhousie’s fast‑paced 3MT finals spotlighted student innovation, with materials engineering PhD student Claire Floras rising to the top by translating complex battery science into a compelling, judge‑winning pitch.
Tuesday, March 17, 2026
A two‑year deep‑energy retrofit has modernized the Killam Memorial Library’s aging systems, boosting efficiency, reducing emissions, and setting the stage for similar upgrades across campus.
Archives - News
Tuesday, November 17, 2020
Marsha Campbell-Yeo, a professor in Dal's School of Nursing, has undertaken a study looking into how families have coped with the new rules in Neonatal Intensive Care Units across Canada.
Monday, November 16, 2020
With the U.S. election now over and president-elect Joe Biden trying to create an orderly transition plan amid continued false accusations of election fraud from President Donald Trump, panelists from a Dal-hosted Open Dialogue event last month have returned to share their reactions.
Friday, November 13, 2020
Following the tragic shooting rampage that cost the lives of 23 Nova Scotians in April, Adrian Delli Colli and Ireland Thurler were spurred to action — walking from Portapique to Enfield to raise money they now plan to use to create a scholarship fund for the victim's families.
Friday, November 13, 2020
Drugmaker Pfizer's news this week that its experimental vaccine is more than 90 percent effective in preventing COVID-19 was met with much jubilance. Dr. Scott Halperin, a professor in the Division of Infectious Diseases, explains what comes next in Pfizer's large-scale clinical trial, how significant a 90 percent efficacy rate is, and how vaccines will be distributed.
Thursday, November 12, 2020
In his latest column, President Deep Saini shares two experiences from the past week where he witnessed the ingenuity of Dal's people in managing the university's activities during the pandemic.